human menopausal gonadotropin (hMG)

DRUG2 trials

Sponsors

EMD Serono, Ercan Bastu

Conditions

Infertile Women Undergoing Assisted Reproductive Technology (ART)Poor Responders

Phase 4

A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation

CompletedNCT00298025

EMD SeronoInfertile Women Undergoing Assisted Reproductive Technology (ART)

Start: 2003-09-30End: 2004-05-31Updated: 2014-03-26

Unknown Phase

Comparison of Treatment Modalities in Poor Responders Undergoing IVF

CompletedNCT02158689

Ercan BastuPoor Responders

Start: 2014-06-30End: 2015-08-31Target: 80Updated: 2016-01-08